Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
Leila Akkari began her independent career in 2017 as an Assistant Professor at the Netherlands Cancer Institute in Amsterdam after working at Memorial Sloan Kettering Cancer Center in NYC. Two years ago, she was selected as one of the junior members of the Oncode Institute, a virtual group of cancer...
Guardado en:
Formato: | article |
---|---|
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/629c0b3d4b2c4a6a91d38d13225d42c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
KRAS mutation: from undruggable to druggable in cancer
por: Lamei Huang, et al.
Publicado: (2021) -
Protein complex evolution does not involve extensive network rewiring.
por: Teunis J P van Dam, et al.
Publicado: (2008) -
Stem cells and art: an interview with Yi Arial Zeng on the promising future of the stem cell field
Publicado: (2021) -
Developing organoids: an interview with Alice Soragni on 3D biology at the interface of treating cancers and protein aggregation
Publicado: (2021) -
Seeing the full picture of brain development: an interview with Aparna Bhaduri on single-cell genomics and developmental neuroscience
Publicado: (2021)